A preclinical study combining oncolytic adenovirus Ad-mTNFα-mIL2 (expressing TNF-α and IL-2) with CAR-T cells targeting mesothelin showed significant tumor attenuation in pancreatic ductal adenocarcinoma models (112). Here, IL2 is linked to pancreatic ductal adenocarcinoma.